OpenAI has launched a biodefense initiative and expanded access to its life sciences-focused AI model, GPT-Rosalind, for select government and public health organizations.
Here are six things to know:
- In a May 29 news release, OpenAI introduced Rosalind Biodefense, a program designed to help developers build biodefense and pandemic preparedness applications using GPT-Rosalind.
- OpenAI said it will sponsor access to the model and provide support for qualified organizations developing tools for epidemiological modeling, early detection, outbreak response planning and other public health preparedness efforts.
- The initiative aims to help organizations use advanced AI to strengthen defenses against biological threats, according to OpenAI.
- OpenAI also said it is expanding access to GPT-Rosalind for select U.S. government and allied partners supporting biodefense missions.
- Organizations receiving access include Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory and the Coalition for Epidemic Preparedness Innovations, according to the announcement.
- OpenAI said the Rosalind Biodefense program is open to qualified applicants globally and that it plans to continue expanding access to GPT-Rosalind over time.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.